Erythromycin Ethylsuccinate Injection
» Erythromycin Ethylsuccinate Injection is a sterile solution of Erythromycin Ethylsuccinate in Polyethylene Glycol 400, and contains 2 percent of butyl aminobenzoate and a suitable preservative. It contains the equivalent of not less than 90.0 percent and not more than 115.0 percent of the labeled amount of erythromycin (C37H67NO13).
Packaging and storage—
Preserve in single-dose or in multiple-dose containers, preferably of Type I glass.
Sterility 
71
—
It meets the requirements when tested as directed for Membrane Filtration under Test for Sterility of the Product to be Examined, using a membrane filter resistant to the solvent effect of polyethylene glycol 400.
71—
It meets the requirements when tested as directed for Membrane Filtration under Test for Sterility of the Product to be Examined, using a membrane filter resistant to the solvent effect of polyethylene glycol 400.
Water, Method I 921:
not more than 1.5%, 20 mL of methanol containing 10% of imidazole being used in place of methanol in the titration vessel.
921:
not more than 1.5%, 20 mL of methanol containing 10% of imidazole being used in place of methanol in the titration vessel.
Other requirements—
It meets the requirements under Injections 1.
1.
Assay—
Proceed as directed for erythromycin under Antibiotics—Microbial Assays 81, using an accurately measured volume of Injection diluted quantitatively with methanol to yield a solution containing the equivalent of about 1 mg of erythromycin per mL. Dilute a portion of this stock solution quantitatively with Buffer No. 3 to obtain a Test Dilution having a concentration assumed to be equal to the median dose level of the Standard.
81, using an accurately measured volume of Injection diluted quantitatively with methanol to yield a solution containing the equivalent of about 1 mg of erythromycin per mL. Dilute a portion of this stock solution quantitatively with Buffer No. 3 to obtain a Test Dilution having a concentration assumed to be equal to the median dose level of the Standard.
Auxiliary Information—
Please check for your question in the FAQs before contacting USP.
| Topic/Question | Contact | Expert Committee |
| Monograph | Ahalya Wise, M.S.
Scientist 1-301-816-8161 |
(MDANT05) Monograph Development-Antibiotics |
| Reference Standards | Lili Wang, Technical Services Scientist 1-301-816-8129 RSTech@usp.org |
|
| 71 |
Radhakrishna S Tirumalai, Ph.D.
Senior Scientist 1-301-816-8339 |
(MSA05) Microbiology and Sterility Assurance |
USP32–NF27 Page 2292